4.8 Article

S2 Subunit of SARS-CoV-2 Spike Protein Induces Domain Fusion in Natural Pulmonary Surfactant Monolayers

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Pulmonary surfactant as a versatile biomaterial to fight COVID-19

Lore Herman et al.

Summary: The COVID-19 pandemic has had a significant impact globally, and while vaccination campaigns have proven effective, there is still a need to develop therapeutics specifically targeting COVID-19. This article highlights the potential of pulmonary surfactant (PS) in treating COVID-19 and its role in enhancing drug delivery.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Chemistry, Multidisciplinary

Strikingly Different Roles of SARS-CoV-2 Fusion Peptides Uncovered by Neutron Scattering

Andreas Santamaria et al.

Summary: This study investigates the role of SARS-CoV-2 Spike fusion peptides in cellular infection using neutron scattering and spectroscopy techniques. The findings reveal that calcium drives the fusion peptides to cross the host plasma membrane, while removal of calcium leads to peptide reorientation and significant changes in lipid properties. Combining with other regions in the fusion domain, the molecular events of cell entry by SARS-CoV-2 are proposed.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Review Cell Biology

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson et al.

Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

Reduced levels of pulmonary surfactant in COVID-19 ARDS

Peter Schousboe et al.

Summary: Our study provides novel data on surfactant levels in adult COVID-19 patients, showing significantly impaired pulmonary surfactant levels, which warrants further research and clinical trials of exogenous surfactant.

SCIENTIFIC REPORTS (2022)

Editorial Material Critical Care Medicine

Surfactant for the Treatment of ARDS in a Patient With COVID-19

Moshe Heching et al.

Summary: The use of exogenous surfactant in the treatment of ARDS in COVID-19 patients may have significant efficacy, improving oxygenation and promoting clinical improvement in patients.

CHEST (2021)

Review Respiratory System

The COVID-19 pandemic: a target for surfactant therapy?

Ruud A. W. Veldhuizen et al.

Summary: The impact of COVID-19 has led to a search for effective treatment approaches, with exogenous surfactant being considered as a potential therapy for COVID-19 patients. The success of this therapy could be influenced by various factors such as mechanical ventilation strategy, timing of treatment, doses delivered, method of delivery, and preparations utilized. Development of enhanced preparations may improve the effectiveness of this treatment approach, and ongoing trials may provide valuable data and insights for further scientific understanding and improved treatment strategies.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Article Biophysics

Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane

Defne Gorgun et al.

Summary: This study investigated the interaction between SARS-CoV2 FP and mammalian cellular membranes using molecular dynamics simulations, demonstrating that FP can deeply penetrate into the membrane and form stable bindings. Based on clustering analysis, it was proposed that the most deeply inserted membrane-bound form may represent the biologically relevant form more closely.

BIOPHYSICAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples

Taruna Madan et al.

Summary: The recombinant fragment of human SP-D (rfhSP-D) significantly reduced SARS-CoV-2 infection and replication by interacting with the spike protein and human ACE-2 receptor.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challenges

Jose Carlos Castillo-Sanchez et al.

Summary: This review examines the complex structure-function relationships of lung surfactant, detailing lipid-protein interactions and membrane structures. It highlights the dynamic nature of surfactant function, emphasizing the need for a comprehensive understanding of its molecular mechanisms in vivo.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Immunology

Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles

Miao-Hsi Hsieh et al.

Summary: Human SP-D plays a significant role in immune surveillance against pathogens, particularly in protecting against SARS-CoV by recognizing the virus's spike glycoprotein. Studies have demonstrated the ability of SP-D to inhibit viral infection by interacting with specific strains, highlighting its therapeutic potential in combating respiratory viruses like SARS-CoV-2.

FRONTIERS IN IMMUNOLOGY (2021)

Article Chemistry, Physical

Y Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane

Stefan L. Schaefer et al.

Summary: The SARS-CoV-2 virus uses the spike protein to attach to cellular membranes of its human host for membrane fusion during infection. Molecular dynamics simulations show that the fusion peptide (FP) can quickly attach to cellular membranes and form a strong anchor, necessary for membrane fusion. The mechanical stability of FP is attributed to a conserved disulfide bridge, allowing it to withstand forces greater than those required for membrane fusion.

JOURNAL OF PHYSICAL CHEMISTRY B (2021)

Article Chemistry, Multidisciplinary

Fusion Peptide of SARS-CoV-2 Spike Rearranges into a Wedge Inserted in Bilayered Micelles

Rama K. Koppisetti et al.

Summary: The fusion peptide of SARS-CoV-2 plays a crucial role in the fusion of viral and cell membranes, with its structure changes affecting the fusion process between the virus and the cell.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Medicine, General & Internal

Acute respiratory distress syndrome

Nuala J. Meyer et al.

Summary: This article summarizes the epidemiology, diagnosis, and treatment of acute respiratory distress syndrome (ARDS), while also discussing the similarities and differences between ARDS caused by COVID-19 and ARDS caused by other factors.

LANCET (2021)

Article Respiratory System

Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study

Simone Piva et al.

Summary: The study demonstrates that surfactant delivery through bronchoscopy at a dose of 720 mg in 150 ml normal saline is feasible and safe for COVID-19 ARDS patients. Surfactant administration did not cause acute decompensation, may reduce mortality and mechanical ventilation duration in COVID-19 ARDS patients. This supports the need for future randomized clinical trials to evaluate the efficacy of meticulous sub-bronchial lavage with surfactant for COVID-19 ARDS patients.

RESPIRATORY RESEARCH (2021)

Letter Immunology

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Shuai Xia et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Article Biophysics

Atomic Force Microscopy Imaging of Adsorbed Pulmonary Surfactant Films

Lu Xu et al.

BIOPHYSICAL JOURNAL (2020)

Article Biochemistry & Molecular Biology

Molecular Architecture of the SARS-CoV-2 Virus

Hangping Yao et al.

Article Multidisciplinary Sciences

Distinct conformational states of SARS-CoV-2 spike protein

Yongfei Cai et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Line tension at lipid phase boundaries as driving force for HIV fusion peptide-mediated fusion

Sung-Tae Yang et al.

NATURE COMMUNICATIONS (2016)

Article Chemistry, Multidisciplinary

Biophysical Influence of Airborne Carbon Nanomaterials on Natural Pulmonary Surfactant

Russell P. Valle et al.

ACS NANO (2015)

Article Biochemistry & Molecular Biology

A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant

Eleonora Keating et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)

Article Multidisciplinary Sciences

Line-Tension Controlled Mechanism for Influenza Fusion

Herre Jelger Risselada et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

Comparative study of clinical pulmonary surfactants using atomic force microscopy

Hong Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)

Article Chemistry, Multidisciplinary

On the Low Surface Tension of Lung Surfactant

Hong Zhang et al.

LANGMUIR (2011)

Review Biochemistry & Molecular Biology

Current perspectives in pulmonary surfactant - Inhibition, enhancement and evaluation

Yi Y. Zuo et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)